Axelyf, Inc. Secures $4.8 Million in Recent SEC Form D Filing

Axelyf, Inc., a biotechnology company based in Chestnut Hill, MA, has filed an SEC Form D indicating a successful fundraising effort. The company raised $4.8 million of a total offering amount of $6.3 million, with the sale date recorded on July 25, 2025.